Psychiatry and Neurology, Neurology · Fort Wayne, IN
NPI
1083828719
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
7956 W Jefferson Blvd
Fort Wayne, IN, 46804
Phone (260) 436-2416
Groups this clinician bills Medicare through
Medicare paid, 2024
$233K
35,522 services
Medicare patients, 2024
465
Average age 71
Drug cost, 2024
$2.0M
3,225 prescriptions
Company payments, 2025
$40K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marlene C Bultemeyer was code J0585 (injection, onabotulinumtoxina, 1 unit), 8,555 times for 14 patients. In total Marlene C Bultemeyer billed 35,522 services in 46 codes, and Medicare paid $233K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 8,555 | 14 | $4.92 | $42K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 2,417 | 13 | $3.93 | $9,490 |
| 99214 Office E&M - Established | Office | 157 | 105 | $76.30 | $12K |
| 99213 Office E&M - Established | Office | 128 | 108 | $46.18 | $5,911 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 120 | 109 | $11.02 | $1,322 |
| 95886 Electrical Nerve Conductivity | Office | 94 | 52 | $61.23 | $5,756 |
| 99204 Office E&M - New | Office | 59 | 59 | $106.65 | $6,293 |
| 95816 Neurologic | Facility | 45 | 43 | $38.07 | $1,713 |
| 64615 Musculoskeletal | Office | 41 | 13 | $101.70 | $4,170 |
| 64612 Musculoskeletal | Office | 38 | 14 | $101.51 | $3,857 |
| 99223 Hospital E&M - Initial | Facility | 37 | 37 | $116.19 | $4,299 |
| 99203 Office E&M - New | Office | 35 | 35 | $71.44 | $2,500 |
| 96413 Chemotherapy Administration | Office | 34 | 13 | $79.40 | $2,700 |
| 95909 Electrical Nerve Conductivity | Office | 29 | 28 | $89.86 | $2,606 |
| 99232 Hospital E&M - Subsequent | Facility | 24 | 20 | $52.90 | $1,270 |
By year: 2022 $372K for 12,011 services; 2023 $441K for 23,456 services; 2024 $233K for 35,522 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marlene C Bultemeyer prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 219 prescriptions and refills. In total Marlene C Bultemeyer wrote 3,225 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 219 | 495 | 59 | $5,514 |
| Levetiracetam Generic | 175 | 383 | 39 | $11K |
| Xcopri Cenobamate | 151 | 189 | 21 | $273K |
| Donepezil Hcl Generic | 146 | 212 | 42 | $1,038 |
| Gabapentin Generic | 120 | 218 | 38 | $2,389 |
| Divalproex Sodium Generic | 98 | 170 | 15 | $5,853 |
| Qulipta Atogepant | 89 | 123 | 22 | $133K |
| Lamotrigine Generic | 87 | 166 | 18 | $1,854 |
| Lacosamide Generic | 86 | 130 | 20 | $14K |
| Clobazam Generic | 81 | 92 | 11 | $15K |
| Memantine Hcl Generic | 76 | 110 | 18 | $2,004 |
| Pregabalin Generic | 75 | 98 | 20 | $2,150 |
| Primidone Generic | 62 | 111 | 16 | $1,228 |
| Memantine Hcl Er Memantine Hcl | 60 | 92 | 13 | $4,079 |
| Topiramate Generic | 58 | 122 | 19 | $530 |
Brand drugs: 755 claims; generic drugs: 2,440 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marlene C Bultemeyer $40K ($40K in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.